WO2016102402A1 - Aqueous composition comprising a 4-(heterocycloalkyl)-benzene-1,3-diol compound, a c2-c4 monoalcohol, and a glycol - Google Patents

Aqueous composition comprising a 4-(heterocycloalkyl)-benzene-1,3-diol compound, a c2-c4 monoalcohol, and a glycol Download PDF

Info

Publication number
WO2016102402A1
WO2016102402A1 PCT/EP2015/080652 EP2015080652W WO2016102402A1 WO 2016102402 A1 WO2016102402 A1 WO 2016102402A1 EP 2015080652 W EP2015080652 W EP 2015080652W WO 2016102402 A1 WO2016102402 A1 WO 2016102402A1
Authority
WO
WIPO (PCT)
Prior art keywords
benzene
diol
tetrahydro
weight
pyran
Prior art date
Application number
PCT/EP2015/080652
Other languages
French (fr)
Inventor
Marie-Lise CHIRON
Véronique Chevalier
Original Assignee
L'oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'oreal filed Critical L'oreal
Publication of WO2016102402A1 publication Critical patent/WO2016102402A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/02Preparations for care of the skin for chemically bleaching or whitening the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/34Alcohols
    • A61K8/345Alcohols containing more than one hydroxy group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42Amides

Definitions

  • An aqueous composition comprising a 4- (heterocycloalkyl) -benzene-1,3-diol compound, a C2-C4 monoalcohol and a glycol
  • the subject of the present invention is a composition, preferably a cosmetic composition, comprising a 4- (heterocycloalkyl) -benzene-1,3-diol compound, at least one C2-C4 monoalcohol and at least one glycol.
  • the 4- (heterocycloalkyl) -benzene-1,3-diol derivatives are compounds used for the treatment of cutaneous signs of aging and more particularly as a depigmenting agent for keratin materials.
  • this compound it is necessary for this compound to be formulated in a solubilized form, and in particular at a high content, such as greater than or equal to 0.20% by weight, in order to make the best use of its activity and it is also preferable that its solubilization is maintained over time to avoid any recrystallization phenomenon during the storage of compositions comprising such a compound.
  • solubilized forms lead to a better bioavailability in the skin than crystallized forms whose crystal size is poorly controlled.
  • bioavailability refers to the molecular penetration of the active agent into the living layers of the skin and in particular of the epidermis. It will be sought that the penetrated concentration is as high as possible, so as to increase the rate of asset reaching the living layers of the skin.
  • “solubilized form” is meant a dispersion of the derivatives according to the invention in a liquid, in the free molecular state, in particular in uncomplexed form. No crystallization of 4- (heterocycloalkyl) -benzene-1,3-diol derivatives is visible to the naked eye or in cross-polarized light microscopy.
  • compositions containing a high level of glycols provide a tacky and greasy feel of the skin.
  • the object of the present invention is precisely to propose a new galenic formulation of the 4- (heterocycloalkyl) -benzene-1,3-diol compounds making it possible to overcome the abovementioned disadvantages, and thus to incorporate these compounds in a form solubilized and durable over time, these compounds being in particular present at a high content.
  • This new galenic formulation of the compounds 4- (heterocycloalkyl) -benzene-1,3-diol makes it possible in particular to improve the efficacy of the active ingredient for the treatment of keratin materials such as the skin.
  • the compositions according to the invention make it possible to use lower amounts of glycols.
  • the inventors have in fact unexpectedly discovered that the combination of at least one 4- (heterocycloalkyl) -benzene-1,3-diol compound with at least one glycol and at least one C2-C4 monoalcohol makes it possible to solubilize this compound while avoiding recrystallization, especially after storage for 1 month at room temperature (25 ° C) and / or at 4 ° C and / or 45 ° C.
  • composition in particular a cosmetic composition, comprising a composition comprising;
  • the present invention also relates to a process for preparing such a composition comprising the following steps:
  • step 1) of said process is the preparation of a solution A by mixing at least one C2-C4 monoalcohol and water by simply contacting with stirring (for example magnetic stirring) at room temperature ( 20-25 ° C).
  • step 2) of said process is the preparation of a solution B by mixing at least one 4- (heterocycloalkyl) -benzene-1,3-diol compound in at least one glycol by heating, in particular by heating at a temperature of 40-60 ° C, preferably at 50 ° C, for 10 minutes with stirring (eg magnetic).
  • step 3) of said process is the mixing of solutions A and B by pouring solution A on solution B at room temperature (the pouring may be in particular drop by drop).
  • the present invention relates to a process for preparing such a composition comprising the following steps:
  • Steps 1 and 2 of said method can be implemented in any order.
  • R1, R2, R3, R4, which may be identical or different, represent:
  • R1 and R2 are interconnected and form a carbon ring with 5 or 6 carbon atoms with the carbon atom to which they are bonded and R3 and R4, identical or different, represent:
  • R1 and R4 are connected together and form a chain - (CH2) 2 - or - (CH2) 3 - and R2 and R3, which are identical or different, represent:
  • X represents an oxygen atom, or a sulfur atom.
  • Y represents a hydrogen, a chlorine atom or a fluorine atom.
  • salts of the compounds of general formula (I) there may be mentioned preferably salts with an organic base or with an inorganic base.
  • Suitable inorganic bases are, for example, potassium hydroxide, sodium hydroxide or calcium hydroxide.
  • Suitable organic bases are, for example, morpholine, piperazine, arginine, lysine.
  • the compounds of general formula (I) may also exist in the form of hydrates or solvates.
  • Suitable solvents for forming solvates are, for example, alcohols such as ethanol or iso-propanol.
  • C1-C4 alkyl denotes a saturated hydrocarbon chain, linear or branched, comprising from 1 to 4 carbon atoms.
  • C1-C4 alkyloxycarbonyl denotes a carboxy radical substituted with an alkyl radical containing from 1 to 4 carbon atoms.
  • C1-C4 alkoxy denotes an oxygen atom substituted by a linear or branched saturated hydrocarbon-based chain containing from 1 to 4 carbon atoms.
  • the isomers are the cis and trans forms relating to the substituents on the heterocycloalkyl at the 4-position of benzene-1,3-diol.
  • the compounds of general formula (I) that are particularly preferred are those for which:
  • R1 represents a hydrogen, a C1-C4 alkyl radical or a hydroxymethyl radical
  • R2 represents a hydrogen
  • R3 represents a hydrogen
  • R4 represents a hydrogen
  • X represents an oxygen atom
  • Y represents a hydrogen or a fluorine atom
  • the compound (d) of formula (I) may be present in the composition according to the invention, in a content ranging from 0.001% to 10% by weight, relative to the total weight of the composition, more particularly in a content ranging from From 0.05% to 5% by weight, and preferably from 0.1% to 3% by weight, and preferably ranging from 0.25% to 2% by weight.
  • composition according to the invention comprises at least one C2-C4 monoalcohol.
  • C2-C4 monoalcohols comprise a hydroxy group and 2 to 4 carbon atoms. Ethanol, propanol, isopropanol, butanol-1, isobutanol and mixtures thereof can be used.
  • the C2-C4 monoalcohol is preferably ethanol.
  • the concentration of C2-C4 monoalcohol can range from 0.1% to 30% by weight, preferably from 0.5% to 15% by weight, preferably from 1% to 10% by weight relative to the total weight of the composition.
  • the weight ratio C 2 -C 4 monohydric alcohol / compound d) of formula (I) present in the composition according to the invention ranges from 1 to 20, preferably from 1.5 to 10.
  • the composition according to The present invention comprises at least one glycol.
  • glycol according to the invention is meant a hydrocarbon chain comprising at least 2 carbon atoms, preferably 2 to 50 carbon atoms, preferably 2 to 20 carbon atoms, preferably having 2 to 10 carbon atoms, and preferably having from 2 to 6 carbon atoms, and bearing two hydroxyl groups.
  • the glycols used in the present invention may have a weight average molecular weight less than or equal to 1000, preferably between 60 and 500.
  • the glycol may be a natural or synthetic glycol.
  • the glycol may have a linear, branched or cyclic structure.
  • the glycol may be chosen from diethylene glycol, propylene glycol, dipropylene glycol, butylene glycol, pentylene glycol, hexylene glycol, 1,3-propanediol, 1,5-pentanediol and polyethylene glycol, in particular having 5 to 50 ethylene oxide groups, and mixtures thereof.
  • the glycol may be chosen from the group consisting of dipropylene glycol, propylene glycol, propanediol-1, 3, butylene glycol, and their mixture, and more particularly dipropylene glycol.
  • the said glycol (s) may be present in a content ranging from 0.5% to 60% by weight, relative to the total weight of the composition, preferably ranging from 5% to 50% by weight. % by weight, and preferably ranging from 10% to 40% by weight, relative to the total weight of the composition.
  • the cosmetic composition according to the present invention comprises water.
  • the amount of water in the composition according to the invention is greater than or equal to 20% by weight, preferably greater than or equal to 50% by weight, and more particularly greater than or equal to 70% by weight. weight relative to the total weight of the composition.
  • the said glycol (s) in accordance with the invention and the water described above may be present in the composition according to the invention in a mass ratio of the said glycol (s) / water, for example ranging from 0.1 to 10, and preferably ranging from 0.3 to 1.5.
  • compositions used according to the invention may comprise a physiologically acceptable medium, that is to say a medium that is suitable for the administration of a composition topically, that is to say compatible with the keratin materials of human beings such as skin, scalp, hair, nails.
  • a physiologically acceptable medium is preferably a cosmetically acceptable medium, that is to say without odor, or unpleasant appearance, and which is perfectly compatible with the topical route of administration.
  • keratin materials is understood to mean the skin, the body, the face and / or the contour of the eyes, the lips, the nails, the mucous membranes, the eyelashes, the eyebrows, the hairs, the scalp and / or the hair, or any other skin area of the body. More particularly, the keratin materials according to the invention are the scalp, the hair, and / or the skin.
  • the keratin materials according to the invention are the scalp and / or the hair.
  • the keratin materials according to the invention is the skin.
  • skin is meant all of the skin of the body, and preferably, the skin of the face, beaulleté, neck, arms and forearms, or even more preferably, the skin of the skin. face, including forehead, nose, cheeks, chin, eye area.
  • the compound of formula (I) is advantageously present in the compositions according to the invention in a solubilized form.
  • composition according to the invention may be intended to be administered topically, that is to say by surface application of the keratin material in question, such as the skin under consideration.
  • composition of the invention may be a cosmetic composition (either intended for cosmetic use) or dermatological.
  • the composition is a cosmetic composition and even more preferentially a cosmetic composition for topical application.
  • cosmetic composition is understood to mean a substance or a preparation intended to be brought into contact with the various superficial parts of the human body, in particular the epidermis, the hair and hair systems, the nails, the lips and the oral mucosa, in particular view, exclusively or mainly, to clean, embellish, perfume, change the appearance, protect, maintain or repair body odors.
  • compositions according to the invention may be in the form of aqueous solutions, hydroalcoholic solutions, oil-in-water (O / W) or water-in-water emulsions. oil (W / O) or multiple (triple: W / O / W or O / W / H), aqueous gels. These compositions are prepared according to the usual methods.
  • the composition may comprise at least one oil.
  • oils there may be mentioned for example:
  • hydrocarbon-based oils of vegetable origin such as liquid triglycerides of fatty acids containing from 4 to 10 carbon atoms, for instance triglycerides of heptanoic or octanoic acids or, for example, sunflower, corn or soybean oils, squash, grape seed, sesame, hazelnut, apricot, macadamia, arara, castor oil, avocado, triglycerides of caprylic / capric acids such as those sold by Stearineries Dubois or those sold under the names "Miglyol 810", “812" and "818" by Dynamit Nobel, jojoba oil, shea butter oil;
  • liquid triglycerides of fatty acids containing from 4 to 10 carbon atoms for instance triglycerides of heptanoic or octanoic acids or, for example, sunflower, corn or soybean oils, squash, grape seed, sesame, hazelnut, apricot, macadamia, ar
  • esters and synthetic ethers in particular of fatty acids, such as the oils of formulas R 1 COOR 2 and R 10 R 2 in which R 1 represents the residue of a fatty acid comprising from 8 to 29 carbon atoms, and R 2 represents a hydrocarbon-based chain , branched or unbranched, containing from 3 to 30 carbon atoms, for example purcellin oil, isononyl isononanoate, isopropyl myristate, 2-ethylhexyl palmitate, stearate of octyl-2-dodecyl, octyl-2-dodecyl erucate, isostearyl isostearate; hydroxylated esters such as isostearyl lactate, octyl hydroxystearate, octyldodecyl hydroxystearate, diisostearyl malate, triisocetyl citrate; heptanoates, octano
  • linear or branched hydrocarbons of mineral or synthetic origin such as paraffin oils, volatile or not, and their derivatives, petroleum jelly, polydecenes, hydrogenated polyisobutene such as sesam oil;
  • fatty alcohols having from 8 to 26 carbon atoms such as cetyl alcohol, stearyl alcohol and their mixture (cetylstearyl alcohol), octyldodecanol, 2-butyloctanol,
  • silicone oils such as volatile or non-volatile polymethylsiloxanes (PDMS) with a linear or cyclic silicone chain, which are liquid or pasty at room temperature, in particular cyclopolydimethylsiloxanes (cyclomethicones) such as cyclohexasiloxane; polydimethylsiloxanes comprising alkyl, alkoxy or phenyl groups, during or at the end of the silicone chain, groups having from 2 to 24 carbon atoms; phenyl silicones such as phenyltrimethicones, phenyldimethicones, phenyltrimethylsiloxydiphenylsiloxanes, diphenyl dimethicones, diphenylmethyldiphenyl trisiloxanes, 2-phenylethyltrimethylsiloxysilicates, and polymethylphenylsiloxanes;
  • PDMS volatile or non-volatile polymethylsiloxanes
  • cyclomethicones
  • hydrocarbon-based oil in the list of oils mentioned above, any oil predominantly comprising carbon and hydrogen atoms, and optionally ester, ether, fluoro, carboxylic acid and / or alcohol groups.
  • composition according to the invention may comprise solid bodies at ambient temperature (25 ° C.), for example fatty acids containing from 8 to 30 carbon atoms, such as stearic acid, lauric acid and palmitic acid. and oleic acid; waxes such as lanolin, beeswax, carnauba or candelilla wax, paraffin waxes, microcrystalline waxes, ceresin or ozokerite, synthetic waxes such as polyethylene waxes, Fischer waxes, Tropsch.
  • fatty acids containing from 8 to 30 carbon atoms such as stearic acid, lauric acid and palmitic acid. and oleic acid
  • waxes such as lanolin, beeswax, carnauba or candelilla wax, paraffin waxes, microcrystalline waxes, ceresin or ozokerite
  • synthetic waxes such as polyethylene waxes, Fischer waxes, Tropsch.
  • fatty substances may be chosen in a varied manner by those skilled in the art in order to prepare a composition having the desired properties, for example of consistency or texture.
  • the composition according to the invention is a water-in-oil (W / O) or oil-in-water (O / W) emulsion.
  • W / O water-in-oil
  • O / W oil-in-water
  • the proportion of the oily phase of the emulsion may range from 1% to 80% by weight, and preferably from 5% to 50% by weight relative to the total weight of the composition.
  • the emulsions generally contain at least one emulsifier, especially chosen from amphoteric, anionic, cationic or nonionic emulsifiers, used alone or as a mixture, and optionally a co-emulsifier.
  • the emulsifiers are suitably selected according to the emulsion to be obtained (W / O or O / W).
  • the emulsifier and the co-emulsifier are generally present in the composition, in a proportion ranging from 0.3 to 30% by weight, and preferably from 0.5 to 20% by weight relative to the total weight of the composition.
  • emulsifiers examples include dimethicone copolyols such as the mixture of cyclomethicone and dimethicone copolyol, sold under the name “DC 5225 C” by Dow Corning, and alkyl dimethicone copolyols such as Laurylmethicone copolyol sold under the name "Dow Corning 5200 Formulation Aid” by the company Dow Corning and Cetyl dimethicone copolyol sold under the name "Abil EM 90®” by the company Goldschmidt.
  • dimethicone copolyols such as the mixture of cyclomethicone and dimethicone copolyol, sold under the name “DC 5225 C” by Dow Corning
  • alkyl dimethicone copolyols such as Laurylmethicone copolyol sold under the name "Dow Corning 5200 Formulation Aid” by the company Dow Corning
  • emulsifiers for example, of nonionic emulsifiers such as oxyalkylenated (more particularly polyoxyethylenated) fatty acid esters of glycerol; oxyalkylenated fatty acid and sorbitan esters; oxyalkylenated fatty acid esters (oxyethylenated and / or oxypropylenated); oxyalkylenated fatty alcohol ethers (oxyethylenated and / or oxypropylenated); sugar esters such as sucrose stearate; and mixtures thereof such as the mixture of glyceryl stearate and PEG-100 stearate.
  • nonionic emulsifiers such as oxyalkylenated (more particularly polyoxyethylenated) fatty acid esters of glycerol; oxyalkylenated fatty acid and sorbitan esters; oxyalkylenated fatty acid esters (oxyethy
  • the composition may be an aqueous gel, and in particular comprise conventional aqueous gelling agents.
  • the composition according to the invention may also contain adjuvants which are customary in the cosmetic or dermatological field, such as gelling agents, thickeners, film-forming polymers, preservatives, perfumes, fillers, UV filters, bactericidal agents, odor absorbers, dyestuffs, plant extracts, vitamins, polyols such as glycerin, diglycerin, sugars such as sorbitol, cosmetic and dermatological active ingredients, and salts.
  • adjuvants which are customary in the cosmetic or dermatological field, such as gelling agents, thickeners, film-forming polymers, preservatives, perfumes, fillers, UV filters, bactericidal agents, odor absorbers, dyestuffs, plant extracts, vitamins, polyols such as glycerin, diglycerin, sugars such as sorbitol, cosmetic and dermatological active ingredients, and salts.
  • the amounts of these various adjuvants are those conventionally used in the field under consideration, and for example from
  • the composition further comprises glycerine.
  • concentration of glycerine may range from 0.1% to 60% by weight, preferably from 1% to 50% by weight, preferably from 5% to 30% by weight relative to the total weight of the composition.
  • the composition according to the invention has a pH ranging from 3 to 7.
  • the pH of the composition ranges from 4 to 6.
  • the subject of the invention is also a process for the cosmetic treatment of skincare, makeup, and / or cleaning of keratinous substances, in particular the skin, comprising the application on said keratin materials, in particular the skin, of a composition according to the invention as described above.
  • Said method of cosmetic treatment of care, makeup, and / or cleansing of the skin is non-therapeutic.
  • the subject of the invention is also a cosmetic process for the depigmentation, lightening and / or bleaching of keratin materials, in particular human skin, hair or hair, comprising the application to said keratin materials of a composition according to the invention. invention as described above.
  • the invention also relates to a cosmetic method for preventing and / or treating cutaneous signs of aging, comprising at least one application step topically on keratin materials, such as the skin, of a composition according to the invention as described above.
  • the cutaneous signs of the aging to be prevented and / or treated in the cosmetic process according to the invention may be chosen from the lines and wrinkles, and / or to fight against the skin withered, soft and / or thinned.
  • the invention also relates to the cosmetic use of a composition according to the invention as defined above, for the care, makeup and / or cleaning of keratin materials.
  • the invention relates to a cosmetic treatment method for the care, makeup, and / or cleaning of keratinous substances, in particular the skin, comprising the administration, topically, to an individual, of a composition as defined above.
  • compositions according to the invention are given by way of illustration and without limitation.
  • the compounds are indicated in chemical name or INCI name.
  • the contents of the ingredients are expressed in percentage by weight.
  • the solution of compound 1 in the glycols is prepared for 10 minutes with magnetic stirring. Water and glycerin and ethanol are then added at room temperature.
  • the stability of the obtained preparation stored at 4 ° C. and at room temperature after 24 hours is evaluated by a macroscopic examination with the eye (observation or not of a cloudiness or a deposit) and by observation under a microscope under a light. polarized (presence or absence of crystals).
  • compositions 1A and 1B in accordance with the invention are stable at room temperature and at 4 ° C., and show no recrystallization of compound 1, this resorcinol derivative is therefore very well solubilized in these particular associations.
  • compositions can be applied regularly to the skin of the face to reduce the signs of skin aging.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Dermatology (AREA)
  • Cosmetics (AREA)

Abstract

The invention relates to a composition comprising: at least one 4-(heterocycloalkyl)-benzene-1,3-diol compound of formula (I); at least one C2-C4 monoalcohol; at least one glycol; and water. The invention also relates to the use of the composition for making-up, caring for and/or cleaning keratin materials, in particular the skin.

Description

Composition aqueuse comprenant un composé 4-(hétérocycloalkyl)-benzene-1 ,3- diol, un monoalcool en C2-C4 et un glycol  An aqueous composition comprising a 4- (heterocycloalkyl) -benzene-1,3-diol compound, a C2-C4 monoalcohol and a glycol
La présente invention a pour objet une composition, de préférence cosmétique, comprenant un composé 4-(hétérocycloalkyl)-benzene-1 ,3-diol, au moins un monoalcool en C2-C4 et au moins un glycol. The subject of the present invention is a composition, preferably a cosmetic composition, comprising a 4- (heterocycloalkyl) -benzene-1,3-diol compound, at least one C2-C4 monoalcohol and at least one glycol.
Les dérivés de 4-(hétérocycloalkyl)-benzene-1 ,3-diol sont des composés utilisés pour le traitement des signes cutanés du vieillissement et plus particulièrement comme agent dépigmentant des matières kératiniques. The 4- (heterocycloalkyl) -benzene-1,3-diol derivatives are compounds used for the treatment of cutaneous signs of aging and more particularly as a depigmenting agent for keratin materials.
Toutefois, ces composés qui se présentent sous forme solide à température ambiante et ont un point de fusion élevé (>210°C) sont difficiles à solubiliser. Ils sont notamment faiblement solubles dans l'eau et la glycérine. However, these compounds which are in solid form at room temperature and have a high melting point (> 210 ° C) are difficult to solubilize. They are notably poorly soluble in water and glycerine.
Or, il nécessaire que ce composé soit formulé sous une forme solubilisée, et notamment à une teneur forte, telle que supérieure ou égale à 0,20% en poids, afin de tirer au mieux profit de son activité et il est également préférable que sa solubilisation soit maintenue au cours du temps pour éviter tout phénomène de recristallisation lors du stockage des compositions comprenant un tel composé. However, it is necessary for this compound to be formulated in a solubilized form, and in particular at a high content, such as greater than or equal to 0.20% by weight, in order to make the best use of its activity and it is also preferable that its solubilization is maintained over time to avoid any recrystallization phenomenon during the storage of compositions comprising such a compound.
En effet les formes solubilisées conduisent à une meilleure biodisponibilité dans la peau que des formes cristallisées dont la taille des cristaux est mal contrôlée. In fact the solubilized forms lead to a better bioavailability in the skin than crystallized forms whose crystal size is poorly controlled.
Par "biodisponibilité", on entend au sens de la présente demande la pénétration moléculaire de l'actif concerné dans les couches vivantes de la peau et en particulier de l'épiderme. On cherchera à ce que la concentration pénétrée soit la plus élevée possible, de façon à augmenter le taux d'actif arrivant jusqu'aux couches vivantes de la peau. For the purposes of this application, the term "bioavailability" refers to the molecular penetration of the active agent into the living layers of the skin and in particular of the epidermis. It will be sought that the penetrated concentration is as high as possible, so as to increase the rate of asset reaching the living layers of the skin.
Par "forme solubilisée", on entend une dispersion des dérivés selon l'invention dans un liquide, à l'état moléculaire libre, en particulier sous forme non complexée. Aucune cristallisation des dérivés 4-(hétérocycloalkyl)-benzene-1 ,3-diol n'est visible à l'œil nu ou en microscopie optique en polarisation croisée. By "solubilized form" is meant a dispersion of the derivatives according to the invention in a liquid, in the free molecular state, in particular in uncomplexed form. No crystallization of 4- (heterocycloalkyl) -benzene-1,3-diol derivatives is visible to the naked eye or in cross-polarized light microscopy.
On cherche donc à augmenter la solubilité de ces actifs mais en utilisant des quantités limitées de solvants qui diminue les propriétés cosmétiques des compositions. Les compositions contenant un taux élévé de glycols apportent un toucher de la peau collant et gras.  It is therefore sought to increase the solubility of these active ingredients but using limited amounts of solvents which reduces the cosmetic properties of the compositions. Compositions containing a high level of glycols provide a tacky and greasy feel of the skin.
La présente invention a précisément pour objet de proposer une nouvelle formulation galénique des composés 4-(hétérocycloalkyl)-benzene-1 ,3-diol permettant de s'affranchir des inconvénients précités, et donc d'incorporer ces composés sous une forme solubilisée et durable dans le temps, ces composés étant notamment présent à une forte teneur. Cette nouvelle formulation galénique des composés 4-(hétérocycloalkyl)-benzene- 1 ,3-diol permet notamment d'améliorer l'efficacité de l'actif pour le traitement des matières kératiniques telles que la peau. Les compositions selon l'invention permettent d'utiliser des quantités inférieures de glycols. The object of the present invention is precisely to propose a new galenic formulation of the 4- (heterocycloalkyl) -benzene-1,3-diol compounds making it possible to overcome the abovementioned disadvantages, and thus to incorporate these compounds in a form solubilized and durable over time, these compounds being in particular present at a high content. This new galenic formulation of the compounds 4- (heterocycloalkyl) -benzene-1,3-diol makes it possible in particular to improve the efficacy of the active ingredient for the treatment of keratin materials such as the skin. The compositions according to the invention make it possible to use lower amounts of glycols.
Les inventeurs ont en effet découvert, de façon inattendue, que l'association d'au moins un composé 4-(hétérocycloalkyl)-benzene-1 ,3-diol avec au moins un glycol et au moins un monoalcool en C2-C4 permet de solubiliser ce composé tout en évitant sa recristallisation, notamment après un stockage de 1 mois à la température ambiante (25 °C) et/ou à 4°C et/ou à 45°C. The inventors have in fact unexpectedly discovered that the combination of at least one 4- (heterocycloalkyl) -benzene-1,3-diol compound with at least one glycol and at least one C2-C4 monoalcohol makes it possible to solubilize this compound while avoiding recrystallization, especially after storage for 1 month at room temperature (25 ° C) and / or at 4 ° C and / or 45 ° C.
De façon plus précise, l'invention a pour objet une composition, notamment cosmétique, comprenant composition comprenant ;  More specifically, the subject of the invention is a composition, in particular a cosmetic composition, comprising a composition comprising;
a) au moins un glycol ;  a) at least one glycol;
b) au moins un monoalcool en C2-C4 ;  b) at least one C2-C4 monoalcohol;
c) de l'eau ;  c) water;
d) au moins un composé 4-(hétérocycloalkyl)-benzene-1 ,3-diol de formule générale (I) tels que définis ci-après. La présente invention concerne également un procédé de préparation d'une telle composition comprenant les étapes suivantes :  d) at least one 4- (heterocycloalkyl) -benzene-1,3-diol compound of general formula (I) as defined below. The present invention also relates to a process for preparing such a composition comprising the following steps:
1 ) préparation d'une solution A par le mélange d'au moins au moins un monoalcool en C2-C4 et de l'eau, et  1) preparing a solution A by mixing at least at least one C2-C4 monoalcohol and water, and
2) préparation d'une solution B par le mélange d'au moins un composé 4- (hétérocycloalkyl)-benzene-l ,3-diol dans au moins un glycol, puis  2) preparing a solution B by mixing at least one 4- (heterocycloalkyl) -benzene-1,3-diol compound in at least one glycol, and
3) mélange des solutions A et B  3) mixing solutions A and B
De préférence l'étape 1 ) dudit procédé est la préparation d'une solution A par le mélange au moins un monoalcool en C2-C4 et de l'eau par simple mise en contact sous agitation ( par exemple agitation magnétique) à température ambiante (20-25°C) . Preferably step 1) of said process is the preparation of a solution A by mixing at least one C2-C4 monoalcohol and water by simply contacting with stirring (for example magnetic stirring) at room temperature ( 20-25 ° C).
De préférence l'étape 2) dudit procédé est la préparation d'une solution B par le mélange d'au moins un composé 4-(hétérocycloalkyl)-benzene-1 ,3-diol dans au moins un glycol par chauffage, notamment en chauffant à une température de 40-60°C, de préférence à 50°C, pendant 10 minutes sous agitation (par exemple magnétique). De préférence l'étape 3) dudit procédé est le mélange des solutions A et B par versement de la solution A sur la solution B à température ambiante (le versement pouvant être notamment goutte à goutte). Particulièrement la présente invention concerne un procédé de préparation d'une telle composition comprenant les étapes suivantes : Preferably step 2) of said process is the preparation of a solution B by mixing at least one 4- (heterocycloalkyl) -benzene-1,3-diol compound in at least one glycol by heating, in particular by heating at a temperature of 40-60 ° C, preferably at 50 ° C, for 10 minutes with stirring (eg magnetic). Preferably step 3) of said process is the mixing of solutions A and B by pouring solution A on solution B at room temperature (the pouring may be in particular drop by drop). In particular, the present invention relates to a process for preparing such a composition comprising the following steps:
1 ) préparation d'une solution A par le mélange d'au moins un monoalcool en C2-C4 et de l'eau, notamment par simple mise en contact sous agitation ( par exemple agitation magnétique) à température ambiante (20-25°C), et  1) preparation of a solution A by mixing at least one C2-C4 monoalcohol and water, in particular by simple contacting with stirring (for example magnetic stirring) at room temperature (20-25 ° C. ), and
2) préparation d'une solution B par le mélange d'au moins un composé 4- (hétérocycloalkyl)-benzene-l ,3-diol dans au moins un glycol, de préférence par chauffage, notamment en chauffant à une température de 40-60°C, de préférence à 50°C, pendant 10 minutes sous agitation (par exemple magnétique) ; puis 2) preparing a solution B by mixing at least one 4- (heterocycloalkyl) -benzene-1,3-diol compound in at least one glycol, preferably by heating, in particular by heating to a temperature of 40- 60 ° C, preferably at 50 ° C, for 10 minutes with stirring (for example magnetic); then
3) mélange des solutions A et B, de préférence par versement de la solution A sur la solution B à température ambiante (le versement pouvant être notamment goutte à goutte). 3) mixing solutions A and B, preferably by pouring solution A on solution B at room temperature (the pouring may be in particular drop by drop).
Les étapes 1 et 2 dudit procédé peuvent être mises en œuvre dans un ordre quelconque. Steps 1 and 2 of said method can be implemented in any order.
Les composés 4-(hétérocycloalkyl)-benzene-1 ,3-diol selon l'invention sont de formule générale (I) suivante : The 4- (heterocycloalkyl) -benzene-1,3-diol compounds according to the invention have the following general formula (I):
Figure imgf000004_0001
dans laquelle
Figure imgf000004_0001
in which
R1 , R2, R3, R4, identiques ou différents, représentent :  R1, R2, R3, R4, which may be identical or different, represent:
- un hydrogène  - a hydrogen
- un radical alkyle en C1 -C4  a C1-C4 alkyl radical
- un hydroxymethyle, un hydroxyethyle,  a hydroxymethyl, a hydroxyethyl,
- un alkoxy C1 -C4 carbonyle,  a C1-C4 alkoxycarbonyl,
- un alkoxy C1 -C4,  a C1-C4 alkoxy,
- un hydroxyle R1 et R2 sont reliés entre eux et forment un cycle carboné à 5 ou 6 atomes de carbone avec l'atome de carbone auquel ils sont liés et R3 et R4, identiques ou différents, représentent : - a hydroxyl R1 and R2 are interconnected and form a carbon ring with 5 or 6 carbon atoms with the carbon atom to which they are bonded and R3 and R4, identical or different, represent:
- un hydrogène  - a hydrogen
- un radical alkyle en C1 -C4  a C1-C4 alkyl radical
ou or
R1 et R4 sont reliés entre eux et forment une chaîne -(CH2)2- ou -(CH2)3- et R2 et R3, identiques ou différents, représentent : R1 and R4 are connected together and form a chain - (CH2) 2 - or - (CH2) 3 - and R2 and R3, which are identical or different, represent:
- un hydrogène  - a hydrogen
- un radical alkyle en C1 -C4  a C1-C4 alkyl radical
X représente un atome d'oxygène, ou un atome de soufre. X represents an oxygen atom, or a sulfur atom.
Y représente un hydrogène, un atome de chlore ou un atome de fluor. Y represents a hydrogen, a chlorine atom or a fluorine atom.
m peut prendre les valeurs 1 ou 2 et n peut prendre les valeurs 0 ou 1 et lorsque n=0, alors m=1 ou 2, et lorsque n=1 , alors m=1 . ainsi que les sels des composés de formule générale (I), et leurs formes isomères et énantiomères. m can take the values 1 or 2 and n can take the values 0 or 1 and when n = 0, then m = 1 or 2, and when n = 1, then m = 1. as well as the salts of the compounds of general formula (I), and their isomeric and enantiomeric forms.
Parmi les sels des composés de formule générale (I), on peut citer de préférence les sels avec une base organique ou avec une base inorganique. Among the salts of the compounds of general formula (I), there may be mentioned preferably salts with an organic base or with an inorganic base.
Les bases inorganiques appropriées sont par exemple l'hydroxyde de potassium, l'hydroxyde de sodium ou l'hydroxyde de calcium.  Suitable inorganic bases are, for example, potassium hydroxide, sodium hydroxide or calcium hydroxide.
Les bases organiques appropriées sont par exemple la morpholine, la piperazine, l'arginine, la lysine.  Suitable organic bases are, for example, morpholine, piperazine, arginine, lysine.
Les composés de formule générale (I), peuvent également exister sous formes d'hydrates ou de solvates. The compounds of general formula (I) may also exist in the form of hydrates or solvates.
Les solvants appropriés pour former des solvates sont par exemple les alcools comme l'éthanol ou l'iso-propanol.  Suitable solvents for forming solvates are, for example, alcohols such as ethanol or iso-propanol.
Selon la présente invention, on désigne par alkyle en C1 -C4 une chaîne hydrocarbonée saturée, linéaire ou ramifiée, comprenant de 1 à 4 atomes de carbone. According to the present invention, the term C1-C4 alkyl denotes a saturated hydrocarbon chain, linear or branched, comprising from 1 to 4 carbon atoms.
Selon la présente invention, on désigne par aikoxy C1 -C4 carbonyle un radical carboxy substitué par un radical alkyle comprenant de 1 à 4 atomes de carbone. Selon la présente invention, on désigne par aikoxy C1 -C4 un atome d'oxygène substitué par une chaîne hydrocarbonée saturée, linéaire ou ramifiée, comprenant de 1 à 4 atomes de carbone. Selon la présente invention, on désigne par isomères les formes cis et trans relatives aux substituants sur l'heterocycloalkyle en position 4 du benzène -1 ,3-diol. According to the present invention, C1-C4 alkyloxycarbonyl denotes a carboxy radical substituted with an alkyl radical containing from 1 to 4 carbon atoms. According to the present invention, C1-C4 alkoxy denotes an oxygen atom substituted by a linear or branched saturated hydrocarbon-based chain containing from 1 to 4 carbon atoms. According to the present invention, the isomers are the cis and trans forms relating to the substituents on the heterocycloalkyl at the 4-position of benzene-1,3-diol.
Selon la présente invention, les composés de formule générale (I) particulièrement préférés sont ceux pour lesquels: According to the present invention, the compounds of general formula (I) that are particularly preferred are those for which:
- R1 représente un hydrogène, un radical alkyle en C1 -C4 ou un radical hydroxyméthyle,R1 represents a hydrogen, a C1-C4 alkyl radical or a hydroxymethyl radical,
- R2 représente un hydrogène, R2 represents a hydrogen,
- R3 représente un hydrogène,  R3 represents a hydrogen,
- R4 représente un hydrogène,  R4 represents a hydrogen,
- X représente un atome d'oxygène  X represents an oxygen atom
- Y représente un hydrogène ou un atome de fluor Y represents a hydrogen or a fluorine atom
- m = 1 et n = 1 , ainsi que les sels de ces composés de formule générale (I), et leurs formes isomères et énantiomères.  m = 1 and n = 1, as well as the salts of these compounds of general formula (I), and their isomeric and enantiomeric forms.
Parmi les composés de formule (I) entrant dans le cadre de la présente invention, on peut notamment citer les suivants : Among the compounds of formula (I) falling within the scope of the present invention, mention may be made in particular of the following:
1 : 4-(tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  1: 4- (tetrahydro-pyran-4-yl) benzene-1,3-diol
2 : 4-(tétrahydro-thiopyran-4-yl)-benzène-1 ,3-diol  2: 4- (tetrahydro-thiopyran-4-yl) -benzene-1,3-diol
3: 4-( cis-2,6-Diméthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol 3: 4- (cis-2,6-Dimethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
4 : trans-4-(2-méthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  4: trans-4- (2-methyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
5 : cis-4-(2-méthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  5: cis-4- (2-methyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
6 : trans-4-(2-Ethyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  6: trans-4- (2-Ethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
7 : cis-4-(2-Ethyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  7: cis-4- (2-Ethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
8 : trans-4-(2-Hydroxyméthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol 8: trans-4- (2-Hydroxymethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
9 : 4-(2,2,6,6-tétraméthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  9: 4- (2,2,6,6-tetramethyltetrahydro-pyran-4-yl) benzene-1,3-diol
10 : 4-(tétrahydro-furan-3-yl)-benzène-1 ,3-diol  10: 4- (tetrahydro-furan-3-yl) -benzene-1,3-diol
1 1 : 4-(tétrahydro-thiophen-3-yl)-benzène-1 ,3-diol  1: 4- (tetrahydro-thiophen-3-yl) -benzene-1,3-diol
12 : 4-(6-Oxa-spiro[4.5]dec-9-yl)-benzène-1 ,3-diol  12: 4- (6-Oxa-spiro [4.5] dec-9-yl) -benzene-1,3-diol
13 : 4-Chloro-6-(tétrahydro-pyran-4-yl)-benzène-1 ,3-diol 13: 4-Chloro-6- (tetrahydro-pyran-4-yl) -benzene-1,3-diol
14 : 4-Fluoro-6-(tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  14: 4-Fluoro-6- (tetrahydro-pyran-4-yl) -benzene-1,3-diol
15 : 4-(2,2-Diethyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  15: 4- (2,2-Diethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
16 : 4-(tétrahydro-pyran-3-yl)-benzène-1 ,3-diol  16: 4- (tetrahydro-pyran-3-yl) -benzene-1,3-diol
17 : trans-4-(5-Hydroxyméthyl-tétrahydro-furan-3-yl)-benzène-1 ,3-diol 18 : cis-4-(5-Hydroxyméthyl-tétrahydro-furan-3-yl)-benzène-1 ,3-diol 17: trans-4- (5-Hydroxymethyl-tetrahydro-furan-3-yl) -benzene-1,3-diol 18: cis-4- (5-Hydroxymethyl-tetrahydro-furan-3-yl) -benzene-1,3-diol
19 : trans-4-Fluoro-6-(5-hydroxyméthyl-tétrahydro-furan-3-yl)-benzène-1 ,3-diol  19: trans-4-Fluoro-6- (5-hydroxymethyl-tetrahydro-furan-3-yl) -benzene-1,3-diol
20 : cis-4-Fluoro-6-(5-hydroxyméthyl-tétrahydro-furan-3-yl)-benzène-1 ,3-diol  20: cis-4-Fluoro-6- (5-hydroxymethyl-tetrahydro-furan-3-yl) -benzene-1,3-diol
21 : trans-4-Fluoro-6-(2-hydroxyméthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  21: trans-4-Fluoro-6- (2-hydroxymethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
22 : cis-4-Fluoro-6-(2-hydroxyméthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol 22: cis-4-Fluoro-6- (2-hydroxymethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
23 : cis-4-(8-Oxa-bicyclo[3.2.1 ]oct-3-yl)-benzène-1 ,3-diol  23: cis-4- (8-Oxa-bicyclo [3.2.1] oct-3-yl) -benzene-1,3-diol
24 : trans-4-(8-Oxa-bicyclo[3.2.1 ]oct-3-yl)-benzène-1 ,3-diol  24: trans-4- (8-Oxa-bicyclo [3.2.1] oct-3-yl) -benzene-1,3-diol
25 : 4-Fluoro-6-(tétrahydro-thiopyran-4-yl)-benzène-1 ,3-diol Ces composés peuvent être préparés selon les modes opératoires décrits dans la demande WO2010063773.  25: 4-Fluoro-6- (tetrahydro-thiopyran-4-yl) -benzene-1,3-diol These compounds may be prepared according to the procedures described in application WO2010063773.
Le composél : 4-(tétrahydro-pyran-4-yl)-benzène-1 ,3-diol est particulièrement préféré.
Figure imgf000007_0001
composé 1
The compound 4- (tetrahydro-pyran-4-yl) -benzene-1,3-diol is particularly preferred.
Figure imgf000007_0001
compound 1
Le composé (d) de formule (I) peut être présent dans la composition selon l'invention, en une teneur allant de 0,001 % à 10 % en poids, par rapport au poids total de la composition, plus particulièrement en une teneur allant de 0,05 % à 5 % en poids, et de préférence allant de 0,1 % à 3 % en poids, et préférentiellement allant de 0,25 % à 2 % en poids. The compound (d) of formula (I) may be present in the composition according to the invention, in a content ranging from 0.001% to 10% by weight, relative to the total weight of the composition, more particularly in a content ranging from From 0.05% to 5% by weight, and preferably from 0.1% to 3% by weight, and preferably ranging from 0.25% to 2% by weight.
La composition selon l'invention comprend au moins un monoalcool en C2-C4. The composition according to the invention comprises at least one C2-C4 monoalcohol.
Les monoalcools en C2-C4 comprennent un groupe hydroxy et de 2 à 4 atomes de carbone. On peut utiliser l'éthanol, le propanol, l'isopropanol, le butanol-1 , l'isobutanol et leurs mélanges. Le monoalcool en C2-C4 est de préférence l'éthanol. C2-C4 monoalcohols comprise a hydroxy group and 2 to 4 carbon atoms. Ethanol, propanol, isopropanol, butanol-1, isobutanol and mixtures thereof can be used. The C2-C4 monoalcohol is preferably ethanol.
La concentration en monoalcool en C2-C4 peut aller de 0,1 % à 30 % en poids, de préférence de 0,5 % à 15 % en poids, de préférence de 1 à 10% en poids par rapport au poids total de la composition. The concentration of C2-C4 monoalcohol can range from 0.1% to 30% by weight, preferably from 0.5% to 15% by weight, preferably from 1% to 10% by weight relative to the total weight of the composition.
Selon un mode de réalisation préféré, le rapport massique monoalcool en C2-C4 /composé d) de formule (I) présents dans la composition selon l'invention va 1 à 20, de préférence de 1 ,5 à 10. La composition selon la présente invention comprend au moins un glycol. Par glycol selon l'invention on entend une chaîne hydrocarbonée comportant au moins 2 atomes de carbone, de préférence de 2 à 50 atomes de carbones, de préférence de 2 à 20 atomes de carbones, de préférence ayant de 2 à 10 atomes de carbone, et préférentiellement ayant de 2 à 6 atomes de carbones, et portant deux groupes hydroxyle. Les glycols utilisés dans la présente invention peuvent présenter une masse moléculaire moyenne en poids inférieure ou égale à 1000, de préférence comprise entre 60 et 500. According to a preferred embodiment, the weight ratio C 2 -C 4 monohydric alcohol / compound d) of formula (I) present in the composition according to the invention ranges from 1 to 20, preferably from 1.5 to 10. The composition according to The present invention comprises at least one glycol. By glycol according to the invention is meant a hydrocarbon chain comprising at least 2 carbon atoms, preferably 2 to 50 carbon atoms, preferably 2 to 20 carbon atoms, preferably having 2 to 10 carbon atoms, and preferably having from 2 to 6 carbon atoms, and bearing two hydroxyl groups. The glycols used in the present invention may have a weight average molecular weight less than or equal to 1000, preferably between 60 and 500.
Le glycol peut être un glycol naturel ou synthétique. Le glycol peut avoir une structure linéaire, ramifiée ou cyclique. The glycol may be a natural or synthetic glycol. The glycol may have a linear, branched or cyclic structure.
Le glycol peut être choisi parmi le diéthylèneglycol, le propylène glycol, le dipropylène glycol, le butylène glycol, le pentylène glycol, l'hexylène glycol, le 1 ,3-propanediol, le 1 ,5- pentanediol, les polyéthylèneglycol, notamment ayant de 5 à 50 groupes d'oxyde d'éthylène, et leurs mélanges. The glycol may be chosen from diethylene glycol, propylene glycol, dipropylene glycol, butylene glycol, pentylene glycol, hexylene glycol, 1,3-propanediol, 1,5-pentanediol and polyethylene glycol, in particular having 5 to 50 ethylene oxide groups, and mixtures thereof.
Plus particulièrement le glycol peut-être choisi dans le groupe constitué du dipropylène glycol, du propylène glycol, du propanediol-1 ,3, du butylène glycol, et leur mélange, et plus particulièrement le dipropylène glycol. More particularly, the glycol may be chosen from the group consisting of dipropylene glycol, propylene glycol, propanediol-1, 3, butylene glycol, and their mixture, and more particularly dipropylene glycol.
Le(s)dit glycol(s) peut(vent) être présent(s) en une teneur allant de 0,5 % à 60 % en poids, par rapport au poids total de la composition, de préférence allant de 5 % à 50 % en poids, et préférentiellement allant de 10 % à 40 % en poids, par rapport au poids total de la composition. The said glycol (s) may be present in a content ranging from 0.5% to 60% by weight, relative to the total weight of the composition, preferably ranging from 5% to 50% by weight. % by weight, and preferably ranging from 10% to 40% by weight, relative to the total weight of the composition.
La composition cosmétique selon la présente invention comprend de l'eau. The cosmetic composition according to the present invention comprises water.
Dans un mode de réalisation préférée, la quantité d'eau dans la composition selon l'invention est supérieure ou égale à 20% en poids, de préférence supérieure ou égale à 50% en poids, et plus particulièrement supérieure ou égale à 70% en poids par rapport au poids total de la composition. In a preferred embodiment, the amount of water in the composition according to the invention is greater than or equal to 20% by weight, preferably greater than or equal to 50% by weight, and more particularly greater than or equal to 70% by weight. weight relative to the total weight of the composition.
Selon un mode de réalisation, le(s)dit glycol(s) conformes à l'invention et l'eau décrits précédemment peuvent être présents dans la composition selon l'invention en un rapport massique le(s)dit glycol(s) /eau , par exemple allant de 0,1 à 10, et de préférence allant de 0,3 à 1 ,5. According to one embodiment, the said glycol (s) in accordance with the invention and the water described above may be present in the composition according to the invention in a mass ratio of the said glycol (s) / water, for example ranging from 0.1 to 10, and preferably ranging from 0.3 to 1.5.
Les compositions utilisées selon l'invention peuvent comprendre un milieu physiologiquement acceptable, c'est-à-dire un milieu convenant à l'administration d'une composition par voie topique, soit c'est-à-dire compatible avec les matières kératiniques d'êtres humains telles que la peau , le cuir chevelu, les cheveux, les ongles. The compositions used according to the invention may comprise a physiologically acceptable medium, that is to say a medium that is suitable for the administration of a composition topically, that is to say compatible with the keratin materials of human beings such as skin, scalp, hair, nails.
Selon l'invention un milieu physiologiquement acceptable est préférentiellement un milieu cosmétiquement acceptable, c'est-à-dire sans odeur, ou aspect désagréable, et qui est parfaitement compatible avec la voie d'administration topique. According to the invention a physiologically acceptable medium is preferably a cosmetically acceptable medium, that is to say without odor, or unpleasant appearance, and which is perfectly compatible with the topical route of administration.
Par matières kératiniques selon l'invention on entend la peau, du corps, visage et/ou contour des yeux, les lèvres, les ongles, les muqueuses, les cils, les sourcils, les poils, le cuir chevelu et/ou les cheveux, ou toute autre zone cutanée du corps. Plus particulièrement les matières kératiniques selon l'invention sont le cuir chevelu, les cheveux, et/ou la peau. The term "keratin materials" according to the invention is understood to mean the skin, the body, the face and / or the contour of the eyes, the lips, the nails, the mucous membranes, the eyelashes, the eyebrows, the hairs, the scalp and / or the hair, or any other skin area of the body. More particularly, the keratin materials according to the invention are the scalp, the hair, and / or the skin.
De préférence les matières kératiniques selon l'invention sont le cuir chevelu et/ou les cheveux.  Preferably, the keratin materials according to the invention are the scalp and / or the hair.
De préférence les matières kératiniques selon l'invention est la peau. Preferably the keratin materials according to the invention is the skin.
Par « la peau», on entend l'ensemble de la peau du corps, et de manière préférée, la peau du visage, du décolleté, du cou, des bras et avant-bras, voire de manière plus préférée encore, la peau du visage, notamment du front, nez, joues, menton, contour des yeux.  By "skin" is meant all of the skin of the body, and preferably, the skin of the face, décolleté, neck, arms and forearms, or even more preferably, the skin of the skin. face, including forehead, nose, cheeks, chin, eye area.
Comme précisé ci-après, le composé de formule (I) est avantageusement présent, dans les compositions conformes à l'invention, sous une forme solubilisée. As specified below, the compound of formula (I) is advantageously present in the compositions according to the invention in a solubilized form.
A titre d'exemple la composition selon l'invention peut-être destinée à être administrée par voie topique, c'est à dire par application en surface de la matière kératinique considérée, telle que la peau considérée. By way of example, the composition according to the invention may be intended to be administered topically, that is to say by surface application of the keratin material in question, such as the skin under consideration.
La composition de l'invention peut être une composition cosmétique (soit destinée à un usage cosmétique) ou dermatologique. Préférentiellement selon l'invention, la composition est une composition cosmétique et encore plus préférentiellement une composition cosmétique d'application topique. The composition of the invention may be a cosmetic composition (either intended for cosmetic use) or dermatological. Preferably, according to the invention, the composition is a cosmetic composition and even more preferentially a cosmetic composition for topical application.
On entend notamment par « composition cosmétique » une substance ou une préparation destinée à être mise en contact avec les diverses parties superficielles du corps humain, notamment l'épiderme, les systèmes pileux et capillaire, les ongles, les lèvres, les muqueuses buccales, en vue, exclusivement ou principalement, de les nettoyer, de les embellir, de les parfumer, d'en modifier l'aspect, de les protéger, de les maintenir en bon état ou de corriger les odeurs corporelles.  The term "cosmetic composition" is understood to mean a substance or a preparation intended to be brought into contact with the various superficial parts of the human body, in particular the epidermis, the hair and hair systems, the nails, the lips and the oral mucosa, in particular view, exclusively or mainly, to clean, embellish, perfume, change the appearance, protect, maintain or repair body odors.
Les compositions selon l'invention peuvent se présenter sous forme de solutions aqueuses, de solutions hydroalcooliques, d'émulsions huile-dans-eau (H/E) ou eau-dans- huile (E/H) ou multiple (triple : E/H/E ou H/E/H), de gels aqueux. Ces compositions sont préparées selon les méthodes usuelles. The compositions according to the invention may be in the form of aqueous solutions, hydroalcoholic solutions, oil-in-water (O / W) or water-in-water emulsions. oil (W / O) or multiple (triple: W / O / W or O / W / H), aqueous gels. These compositions are prepared according to the usual methods.
La composition peut comprendre au moins une huile. Comme huiles utilisables, on peut citer par exemple : The composition may comprise at least one oil. As usable oils, there may be mentioned for example:
- les huiles hydrocarbonées d'origine végétale, telles que les triglycérides liquides d'acides gras comportant de 4 à 10 atomes de carbone comme les triglycérides des acides heptanoïque ou octanoïque ou encore, par exemple les huiles de tournesol, de maïs, de soja, de courge, de pépins de raisin, de sésame, de noisette, d'abricot, de macadamia, d'arara, de ricin, d'avocat, les triglycérides des acides caprylique/caprique comme ceux vendus par la société Stearineries Dubois ou ceux vendus sous les dénominations « Miglyol 810 », « 812 » et « 818 » par la société Dynamit Nobel, l'huile de jojoba, l'huile de beurre de karité;  hydrocarbon-based oils of vegetable origin, such as liquid triglycerides of fatty acids containing from 4 to 10 carbon atoms, for instance triglycerides of heptanoic or octanoic acids or, for example, sunflower, corn or soybean oils, squash, grape seed, sesame, hazelnut, apricot, macadamia, arara, castor oil, avocado, triglycerides of caprylic / capric acids such as those sold by Stearineries Dubois or those sold under the names "Miglyol 810", "812" and "818" by Dynamit Nobel, jojoba oil, shea butter oil;
- les esters et les éthers de synthèse, notamment d'acides gras, comme les huiles de formules R1 COOR2 et R10R2 dans laquelle R1 représente le reste d'un acide gras comportant de 8 à 29 atomes de carbone, et R2 représente une chaîne hydrocarbonée, ramifiée ou non, contenant de 3 à 30 atomes de carbone, comme par exemple l'huile de Purcellin, l'isononanoate d'isononyle, le myristate d'isopropyle, le palmitate d'éthyl-2- hexyle, le stéarate d'octyl-2-dodécyle, l'érucate d'octyl-2-dodécyle, l'isostéarate d'isostéaryle ; les esters hydroxylés comme l'isostéaryl lactate, l'octylhydroxystéarate, l'hydroxystéarate d'octyldodécyle, le diisostéaryl-malate, le citrate de triisocétyle ; les heptanoates, octanoates, décanoates d'alcools gras ; les esters de polyol, comme le dioctanoate de propylène glycol, le diheptanoate de néopentylglycol et le diisononanoate de diéthylèneglycol ; et les esters du pentaérythritol comme le tétraisostéarate de pentaérythrityle ;  esters and synthetic ethers, in particular of fatty acids, such as the oils of formulas R 1 COOR 2 and R 10 R 2 in which R 1 represents the residue of a fatty acid comprising from 8 to 29 carbon atoms, and R 2 represents a hydrocarbon-based chain , branched or unbranched, containing from 3 to 30 carbon atoms, for example purcellin oil, isononyl isononanoate, isopropyl myristate, 2-ethylhexyl palmitate, stearate of octyl-2-dodecyl, octyl-2-dodecyl erucate, isostearyl isostearate; hydroxylated esters such as isostearyl lactate, octyl hydroxystearate, octyldodecyl hydroxystearate, diisostearyl malate, triisocetyl citrate; heptanoates, octanoates, decanoates of fatty alcohols; polyol esters, such as propylene glycol dioctanoate, neopentyl glycol diheptanoate and diethylene glycol diisononanoate; and pentaerythritol esters such as pentaerythrityl tetraisostearate;
- les hydrocarbures linéaires ou ramifiés, d'origine minérale ou synthétique, tels que les huiles de paraffine, volatiles ou non, et leurs dérivés, la vaseline, les polydécènes, le polyisobutène hydrogéné tel que l'huile de parléam ;  linear or branched hydrocarbons of mineral or synthetic origin, such as paraffin oils, volatile or not, and their derivatives, petroleum jelly, polydecenes, hydrogenated polyisobutene such as parleam oil;
- les alcools gras ayant de 8 à 26 atomes de carbone, comme l'alcool cétylique, l'alcool stéarylique et leur mélange (alcool cétylstéarylique), l'octyldodécanol, le 2-butyloctanol, le fatty alcohols having from 8 to 26 carbon atoms, such as cetyl alcohol, stearyl alcohol and their mixture (cetylstearyl alcohol), octyldodecanol, 2-butyloctanol,
2-hexyldécanol, le 2-undécylpentadécanol, l'alcool oléique ou l'alcool linoléique ; 2-hexyldecanol, 2-undecylpentadecanol, oleic alcohol or linoleic alcohol;
- les huiles de silicone comme les polyméthylsiloxanes (PDMS) volatiles ou non à chaîne siliconée linéaire ou cyclique, liquides ou pâteux à température ambiante, notamment les cyclopolydiméthylsiloxanes (cyclométhicones) telles que la cyclohexasiloxane ; les polydiméthylsiloxanes comportant des groupements alkyle, alcoxy ou phényle, pendant ou en bout de chaîne siliconée, groupements ayant de 2 à 24 atomes de carbone ; les silicones phénylées comme les phényltriméthicones, les phényldiméthicones, les phényltriméthylsiloxydiphényl-siloxanes, les diphényl-diméthicones, les diphénylméthyldiphényl trisiloxanes, les 2-phényléthyltriméthyl-siloxysilicates, et les polyméthylphénylsiloxanes ; silicone oils such as volatile or non-volatile polymethylsiloxanes (PDMS) with a linear or cyclic silicone chain, which are liquid or pasty at room temperature, in particular cyclopolydimethylsiloxanes (cyclomethicones) such as cyclohexasiloxane; polydimethylsiloxanes comprising alkyl, alkoxy or phenyl groups, during or at the end of the silicone chain, groups having from 2 to 24 carbon atoms; phenyl silicones such as phenyltrimethicones, phenyldimethicones, phenyltrimethylsiloxydiphenylsiloxanes, diphenyl dimethicones, diphenylmethyldiphenyl trisiloxanes, 2-phenylethyltrimethylsiloxysilicates, and polymethylphenylsiloxanes;
- leurs mélanges. On entend par « huile hydrocarbonée » dans la liste des huiles citées ci-dessus, toute huile comportant majoritairement des atomes de carbone et d'hydrogène, et éventuellement des groupements ester, éther, fluoré, acide carboxylique et/ou alcool. - their mixtures. The term "hydrocarbon-based oil" in the list of oils mentioned above, any oil predominantly comprising carbon and hydrogen atoms, and optionally ester, ether, fluoro, carboxylic acid and / or alcohol groups.
La composition selon l'invention peut comprendre des corps solides à la température ambiante (25°C) comme par exemple les acides gras comportant de 8 à 30 atomes de carbone, comme l'acide stéarique, l'acide laurique, l'acide palmitique et l'acide oléique ; les cires comme la lanoline, la cire d'abeille, la cire de Carnauba ou de Candellila, les cires de paraffine, les cires microcristallines, la cérésine ou l'ozokérite, les cires synthétiques comme les cires de polyéthylène, les cires de Fischer-Tropsch. The composition according to the invention may comprise solid bodies at ambient temperature (25 ° C.), for example fatty acids containing from 8 to 30 carbon atoms, such as stearic acid, lauric acid and palmitic acid. and oleic acid; waxes such as lanolin, beeswax, carnauba or candelilla wax, paraffin waxes, microcrystalline waxes, ceresin or ozokerite, synthetic waxes such as polyethylene waxes, Fischer waxes, Tropsch.
Ces corps gras peuvent être choisis de manière variée par l'homme du métier afin de préparer une composition ayant les propriétés, par exemple de consistance ou de texture, souhaitées. These fatty substances may be chosen in a varied manner by those skilled in the art in order to prepare a composition having the desired properties, for example of consistency or texture.
Selon un mode particulier de réalisation de l'invention, la composition selon l'invention est une émulsion eau-dans-huile (E/H) ou huile-dans-eau (H/E). La proportion de la phase huileuse de l'émulsion peut aller de 1 % à 80 % en poids, et de préférence de 5 % à 50 % en poids par rapport au poids total de la composition. According to a particular embodiment of the invention, the composition according to the invention is a water-in-oil (W / O) or oil-in-water (O / W) emulsion. The proportion of the oily phase of the emulsion may range from 1% to 80% by weight, and preferably from 5% to 50% by weight relative to the total weight of the composition.
Les émulsions contiennent généralement au moins un émulsionnant, notamment choisi parmi les émulsionnants amphotères, anioniques, cationiques ou non ioniques, utilisés seuls ou en mélange, et éventuellement un co-émulsionnant. Les émulsionnants sont choisis de manière appropriée suivant l'émulsion à obtenir (E/H ou H/E). L'émulsionnant et le co-émulsionnant sont généralement présents dans la composition, en une proportion allant de 0,3 à 30 % en poids, et de préférence de 0,5 à 20 % en poids par rapport au poids total de la composition. The emulsions generally contain at least one emulsifier, especially chosen from amphoteric, anionic, cationic or nonionic emulsifiers, used alone or as a mixture, and optionally a co-emulsifier. The emulsifiers are suitably selected according to the emulsion to be obtained (W / O or O / W). The emulsifier and the co-emulsifier are generally present in the composition, in a proportion ranging from 0.3 to 30% by weight, and preferably from 0.5 to 20% by weight relative to the total weight of the composition.
Pour les émulsions E/H, on peut citer par exemple comme émulsionnants les dimethicone copolyols tels que le mélange de cyclomethicone et de dimethicone copolyol, vendu sous la dénomination « DC 5225 C » par la société Dow Corning, et les alkyl-dimethicone copolyols tels que le Laurylmethicone copolyol vendu sous la dénomination « Dow Corning 5200 Formulation Aid » par la société Dow Corning et le Cetyl dimethicone copolyol vendu sous la dénomination « Abil EM 90® » par la société Goldschmidt. Pour les émulsions H/E, on peut citer par exemple comme émulsionnants, les émulsionnants non ioniques tels que les esters d'acides gras et de glycérol oxyalkylénés (plus particulièrement polyoxyéthylénés) ; les esters d'acides gras et de sorbitan oxyalkylénés ; les esters d'acides gras oxyalkylénés (oxyéthylénés et/ou oxypropylénés) ; les éthers d'alcools gras oxyalkylénés (oxyéthylénés et/ou oxypropylénés) ; les esters de sucres comme le stéarate de sucrose ; et leurs mélanges tels que le mélange de stéarate de glycéryle et de stéarate de PEG-100. For the W / O emulsions, examples of emulsifiers that may be mentioned include dimethicone copolyols such as the mixture of cyclomethicone and dimethicone copolyol, sold under the name "DC 5225 C" by Dow Corning, and alkyl dimethicone copolyols such as Laurylmethicone copolyol sold under the name "Dow Corning 5200 Formulation Aid" by the company Dow Corning and Cetyl dimethicone copolyol sold under the name "Abil EM 90®" by the company Goldschmidt. For O / W emulsions, mention may be made, for example, as emulsifiers, of nonionic emulsifiers such as oxyalkylenated (more particularly polyoxyethylenated) fatty acid esters of glycerol; oxyalkylenated fatty acid and sorbitan esters; oxyalkylenated fatty acid esters (oxyethylenated and / or oxypropylenated); oxyalkylenated fatty alcohol ethers (oxyethylenated and / or oxypropylenated); sugar esters such as sucrose stearate; and mixtures thereof such as the mixture of glyceryl stearate and PEG-100 stearate.
La composition peut être un gel aqueux , et notamment comprendre des gélifiants aqueux usuels. The composition may be an aqueous gel, and in particular comprise conventional aqueous gelling agents.
De façon connue, la composition selon l'invention peut contenir également des adjuvants habituels dans le domaine cosmétique ou dermatologique tels que les gélifiants, les épaississants les polymères filmogènes, les conservateurs, les parfums, les charges, les filtres UV, les bactéricides, les absorbeurs d'odeur, les matières colorantes, les extraits végétaux, les vitamines, les polyols tels que la glycérine, la diglycérine, les sucres tels que le sorbitol, les actifs cosmétiques et dermatologiques, et les sels. Les quantités de ces différents adjuvants sont celles classiquement utilisées dans le domaine considéré, et par exemple de 0,001 à 20 % du poids total de la composition. In a known manner, the composition according to the invention may also contain adjuvants which are customary in the cosmetic or dermatological field, such as gelling agents, thickeners, film-forming polymers, preservatives, perfumes, fillers, UV filters, bactericidal agents, odor absorbers, dyestuffs, plant extracts, vitamins, polyols such as glycerin, diglycerin, sugars such as sorbitol, cosmetic and dermatological active ingredients, and salts. The amounts of these various adjuvants are those conventionally used in the field under consideration, and for example from 0.001 to 20% of the total weight of the composition.
Selon l'invention la composition comprend en outre de la glycérine. La concentration en glycérine peut aller de 0,1 % à 60 % en poids, de préférence de 1 % à 50 % en poids, de préférence de 5 à 30% en poids par rapport au poids total de la composition. According to the invention the composition further comprises glycerine. The concentration of glycerine may range from 0.1% to 60% by weight, preferably from 1% to 50% by weight, preferably from 5% to 30% by weight relative to the total weight of the composition.
Avantageusement, la composition selon l'invention a un pH allant de 3 à 7. De préférence, le pH de la composition va de 4 à 6. Advantageously, the composition according to the invention has a pH ranging from 3 to 7. Preferably, the pH of the composition ranges from 4 to 6.
Plus particulièrement l'invention a encore pour objet un procédé de traitement cosmétique de soin, de maquillage, et/ou de nettoyage des matières kératiniques, notamment la peau, comprenant l'application sur sur lesdites matières kératiniques, notamment la peau, d'une composition selon l'invention telle que décrite précédemment. More particularly, the subject of the invention is also a process for the cosmetic treatment of skincare, makeup, and / or cleaning of keratinous substances, in particular the skin, comprising the application on said keratin materials, in particular the skin, of a composition according to the invention as described above.
Ledit procédé de traitement cosmétique de soin, de maquillage, et/ou de nettoyage de la peau est non thérapeutique.  Said method of cosmetic treatment of care, makeup, and / or cleansing of the skin is non-therapeutic.
L'invention a également pour objet un procédé cosmétique de dépigmentation, d'éclaircissement et/ou de blanchiment des matières kératiniques, notamment la peau humaine, les poils ou les cheveux comprenant l'application sur lesdites matières kératiniques d'une composition selon l'invention telle que décrite précédemment.  The subject of the invention is also a cosmetic process for the depigmentation, lightening and / or bleaching of keratin materials, in particular human skin, hair or hair, comprising the application to said keratin materials of a composition according to the invention. invention as described above.
L'invention a encore pour objet un procédé cosmétique de prévention et/ou de traitement des signes cutanés du vieillissement, comprenant au moins une étape d'application topique sur les matières kératiniques, telles que la peau, d'une composition selon l'invention telle que décrite précédemment. The invention also relates to a cosmetic method for preventing and / or treating cutaneous signs of aging, comprising at least one application step topically on keratin materials, such as the skin, of a composition according to the invention as described above.
Les signes cutanés du vieillissement à prévenir et/ou traiter dans le procédé cosmétique selon l'invention peuvent être choisis parmi les rides et ridules, et/ou de lutter contre la peau flétrie, molle et/ou amincie.  The cutaneous signs of the aging to be prevented and / or treated in the cosmetic process according to the invention may be chosen from the lines and wrinkles, and / or to fight against the skin withered, soft and / or thinned.
L'invention a également pour objet l'utilisation cosmétique d'une composition selon l'invention telle que définie précédemment, pour le soin, le maquillage et/ou le nettoyage des matières kératiniques. The invention also relates to the cosmetic use of a composition according to the invention as defined above, for the care, makeup and / or cleaning of keratin materials.
Dans un autre mode de réalisation, l'invention concerne un procédé de traitement cosmétique de soin, de maquillage, et/ou de nettoyage des matières kératiniques, notamment la peau, comprenant l'administration, par voie topique, à un individu, d'une composition telle que définie précédemment. In another embodiment, the invention relates to a cosmetic treatment method for the care, makeup, and / or cleaning of keratinous substances, in particular the skin, comprising the administration, topically, to an individual, of a composition as defined above.
Les expressions « compris entre ... et ... » et « allant de ... à ... », ou « au moins .. », ou « au moins de.. » doivent se comprendre bornes incluses, sauf si le contraire est spécifié. Les exemples ci-après de compositions selon l'invention sont donnés à titre d'illustration et sans caractère limitatif. Les composés sont indiqués en nom chimique ou en nom INCI.The expressions "between ... and ..." and "from ... to ...", or "at least ..", or "at least .." must be understood as inclusive, unless the opposite is specified. The following examples of compositions according to the invention are given by way of illustration and without limitation. The compounds are indicated in chemical name or INCI name.
Les teneurs des ingrédients sont exprimées en pourcentage pondéral. The contents of the ingredients are expressed in percentage by weight.
Exemple 1 : Evaluation de la stabilité de formulations Example 1: Evaluation of the stability of formulations
Mode de préparation : Method of preparation :
On prépare la solution de composé 1 dans les glycols pendant 10 minutes sous agitation magnétique. On ajoute ensuite l'eau et la glycérine et Γ éthanol à température ambiante.  The solution of compound 1 in the glycols is prepared for 10 minutes with magnetic stirring. Water and glycerin and ethanol are then added at room temperature.
Protocole d'évaluation: Evaluation Protocol:
On évalue la stabilité de la préparation obtenue conservée à 4°C et à température ambiante au bout de 24H par un contrôle macroscopique à l'œil (observation ou non d'un trouble ou d'un dépôt) et par observation au microscope sous lumière polarisée (présence ou non de cristaux).  The stability of the obtained preparation stored at 4 ° C. and at room temperature after 24 hours is evaluated by a macroscopic examination with the eye (observation or not of a cloudiness or a deposit) and by observation under a microscope under a light. polarized (presence or absence of crystals).
On a obtenu les résultats suivants avec différentes associations évaluées: Compo 1 Compo 2 Compo 1A Compo 1 B comparative comparative invention inventionThe following results were obtained with different associations evaluated: Compo 1 Compo 2 Compo 1A Compo 1 B comparative comparative invention
Composé 1 1 ,5 1 ,5 1 ,5 1 ,5 Compound 1 1, 5 1, 5 1, 5 1, 5
Dipropylène 15 22,5 15 30 glycol  Dipropylene 15 22.5 15 30 glycol
Propylène glycol 3,75 7,5 7,5 3,75  Propylene glycol 3.75 7.5 7.5 3.75
Butylène glycol 1 1 ,25 7,5 15 3,75 Butylene glycol 1 1, 25 7.5 15 3.75
Ethanol 0 0 8 5,33  Ethanol 0 0 8 5.33
Glycérine 8 8 8 8 Glycerin 8 8 8 8
Eau QSP 100% QSP 100 % QSP 100 % QSP 100 %  Water QSP 100% QSP 100% QSP 100% QSP 100%
Quantité totale 30% 37,5% 37,5% 37,5% de glycols Total amount 30% 37.5% 37.5% 37.5% glycols
Stabilité On observe On observe Pas de Pas de  Stability We observe We observe no steps
immédiateme immédiatement cristaux cristaux  immediately immediately crystals crystals
nt une une après 2 mois après 2 cristallisation cristallisation du à 4°C et à mois à 4°C du composé composé 1 température et à  one after 2 months after crystallization crystallization at 4 ° C and at 4 ° C of the compound 1 temperature compound and at
1 ambiante température ambiante  1 ambient room temperature
On a ainsi constaté que de manière inattendue que les compositions 1A, et 1 B conformes à l'invention , sont stables à température ambiante et à 4°C, et ne présentent aucune recristallisation du composé 1 , ce dérivé de résorcinol est donc très bien solubilisé dans ces associations particulières. It has thus been found that, unexpectedly, compositions 1A and 1B in accordance with the invention are stable at room temperature and at 4 ° C., and show no recrystallization of compound 1, this resorcinol derivative is therefore very well solubilized in these particular associations.
Exemples 2 à 4 Examples 2 to 4
On a préparé les compositions suivantes The following compositions were prepared
Composition en %MA 2 3 4 Composition in% MA 2 3 4
Composé 1 1 0,5 1 ,3 Compound 1 1 0.5 1, 3
Dipropylène glycol 12 15 15Dipropylene glycol 12 15 15
Butylène glycol 10 Butylene glycol 10
Propylène glycol 5  Propylene glycol 5
Glycérine 5 5 10 Glycerin 5 5 10
Disodium EDTA 0,2Disodium EDTA 0.2
Caprylyl glycol 0,2 0,2 0,2 Phénoxyéthanol Caprylyl glycol 0.2 0.2 0.2 phenoxyethanol
0,4 0,4 0,4 0.4 0.4 0.4
Polysorbate 60 0,7 0,7 0,7Polysorbate 60 0.7 0.7 0.7
Acide stéarique 0,5 0,5 0,5Stearic acid 0.5 0.5 0.5
GLYCERYL STEARATE (and) GLYCERYL STEARATE (and)
PEG-100 STEARATE (ARLACEL® 1 ,6 1 ,6 1 ,6 165 FL de chez Uniqema)  PEG-100 STEARATE (ARLACEL® 1, 6 1, 6 1, 6 165 FL from Uniqema)
Octyl dodécanol 1 1 1 Octyl dodecanol 1 1 1
Tocopherol 0,1Tocopherol 0.1
Alcool cétylique 1 1 1Cetyl alcohol 1 1 1
Isoparaffine (Parleam de NOF) 1 1 1Isoparaffin (Parleam of NOF) 1 1 1
Gomme de xanthane 0,2 0,2 0,20.2 0.2 0.2 xanthan gum
Cyclohexasiloxane 1 1 1 1 1 1Cyclohexasiloxane 1 1 1 1 1 1 1
Homopolymère réticulé d'acide Crosslinked homopolymer of acid
acrylamidométhyl propane  acrylamidomethyl propane
sulfonique neutralisé partiellement à 2 2 2 l'ammoniaque (Hostacerin AMPS® sulfonic acid partially neutralized to 2 2 2 ammonia (Hostacerin AMPS ®
de chez Clariant)  from Clariant)
Eau QSP 100% QSP 100% QSP 100% Water QSP 100% QSP 100% QSP 100%
Ethanol 5 5 Ethanol 5 5
10 10
Stabilité Pas de Pas de Pas de cristaux après cristaux après cristaux 2 mois à 4°C 2 mois à 4°C après 2 mois et à et à à 4°C et à température température température ambiante ambiante ambiante Stability No No Crystal Paste after crystals after crystals 2 months at 4 ° C 2 months at 4 ° C after 2 months and at and at 4 ° C and at room temperature ambient temperature
Ces compositions peuvent être appliquées régulièrement sur la peau du visage afin d'atténuer les signes de vieillissement cutané. These compositions can be applied regularly to the skin of the face to reduce the signs of skin aging.

Claims

REVENDICATIONS
1 . Composition comprenant : 1. Composition comprising:
a) au moins un glycol ;  a) at least one glycol;
b) au moins un monoalcool en C2-C4 ;  b) at least one C2-C4 monoalcohol;
c) de l'eau ;  c) water;
d) au moins un composé 4-(hétérocycloalkyl)-benzene-1 ,3-diol de formule générale (I) suivante :  d) at least one 4- (heterocycloalkyl) -benzene-1,3-diol compound of the following general formula (I):
Figure imgf000016_0001
Figure imgf000016_0001
dans laquelle in which
R1 , R2, R3, R4, identiques ou différents, représentent :  R1, R2, R3, R4, which may be identical or different, represent:
- un hydrogène,  a hydrogen,
- un radical alkyle en C1 -C4,  a C1-C4 alkyl radical,
- un hydroxymethyle, un hydroxyethyle,  a hydroxymethyl, a hydroxyethyl,
- un alkoxy C1 -C4 carbonyle,  a C1-C4 alkoxycarbonyl,
- un alkoxy C1 -C4,  a C1-C4 alkoxy,
- un hydroxyle,  a hydroxyl,
ou or
R1 et R2 sont reliés entre eux et forment un cycle carboné à 5 ou 6 atomes de carbone avec l'atome de carbone auquel ils sont liés et R3 et R4, identiques ou différents, représentent : R1 and R2 are interconnected and form a carbon ring with 5 or 6 carbon atoms with the carbon atom to which they are bonded and R3 and R4, identical or different, represent:
- un hydrogène  - a hydrogen
- un radical alkyle en C1 -C4  a C1-C4 alkyl radical
ou or
R1 et R4 sont reliés entre eux et forment une chaîne (CH2)2- ou -(CH2)3- et R2 et R3, identiques ou différents, représentent : R1 and R4 are connected together and form a chain (CH2) 2 - or - (CH2) 3 - and R2 and R3, which may be identical or different, represent:
- un hydrogène  - a hydrogen
- un radical alkyle en C1 -C4  a C1-C4 alkyl radical
X représente un atome d'oxygène, ou un atome de soufre. X represents an oxygen atom, or a sulfur atom.
Y représente un hydrogène, un atome de chlore ou un atome de fluor. m peut prendre les valeurs 1 ou 2 et n peut prendre les valeurs 0 ou 1 et lorsque n=0, alors m=1 ou 2, et lorsque n=1 , alors m=1. Y represents a hydrogen, a chlorine atom or a fluorine atom. m can take the values 1 or 2 and n can take the values 0 or 1 and when n = 0, then m = 1 or 2, and when n = 1, then m = 1.
ainsi que les sels des composés de formule générale (I), et leurs formes isomères et énantiomères, les hydrates et les solvates. as well as the salts of the compounds of general formula (I), and their isomeric and enantiomeric forms, hydrates and solvates.
2 - Composition selon la revendication 1 caractérisé en ce que dans le composé d) de formule (I): 2 - Composition according to claim 1 characterized in that in the compound d) of formula (I):
- R1 représente un hydrogène, un radical alkyle en C1 -C4 ou un radical hydroxyméthyle, R1 represents a hydrogen, a C1-C4 alkyl radical or a hydroxymethyl radical,
- R2 représente un hydrogène, R2 represents a hydrogen,
- R3 représente un hydrogène, R3 represents a hydrogen,
- R4 représente un hydrogène,  R4 represents a hydrogen,
- X représente un atome d'oxygène  X represents an oxygen atom
- Y représente un hydrogène ou un atome de fluor  Y represents a hydrogen or a fluorine atom
- m = 1 et n = 1 ,  - m = 1 and n = 1,
ainsi que les sels de ces composés et leurs formes isomères et énantiomères, , les hydrates et les solvates. as well as the salts of these compounds and their isomeric and enantiomeric forms, hydrates and solvates.
3 - Composition selon l'une des revendications 1 à 2 caractérisé en ce que le ou les composés de formule (I) sont choisis dans le groupe constitué par : 3 - Composition according to one of claims 1 to 2 characterized in that the compound (s) of formula (I) are chosen from the group consisting of:
1 : 4-(tétrahydro-pyran-4-yl)-benzène-1 ,3-diol 1: 4- (tetrahydro-pyran-4-yl) benzene-1,3-diol
2 : 4-(tétrahydro-thiopyran-4-yl)-benzène-1 ,3-diol  2: 4- (tetrahydro-thiopyran-4-yl) -benzene-1,3-diol
3: 4-( cis-2,6-Diméthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  3: 4- (cis-2,6-Dimethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
4 : trans-4-(2-méthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  4: trans-4- (2-methyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
5 : cis-4-(2-méthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  5: cis-4- (2-methyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
6 : trans-4-(2-Ethyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol 6: trans-4- (2-Ethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
7 : cis-4-(2-Ethyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  7: cis-4- (2-Ethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
8 : trans-4-(2-Hydroxyméthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  8: trans-4- (2-Hydroxymethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
9 : 4-(2,2,6,6-tétraméthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  9: 4- (2,2,6,6-tetramethyltetrahydro-pyran-4-yl) benzene-1,3-diol
10 : 4-(tétrahydro-furan-3-yl)-benzène-1 ,3-diol  10: 4- (tetrahydro-furan-3-yl) -benzene-1,3-diol
1 1 : 4-(tétrahydro-thiophen-3-yl)-benzène-1 ,3-diol 1: 4- (tetrahydro-thiophen-3-yl) -benzene-1,3-diol
12 : 4-(6-Oxa-spiro[4.5]dec-9-yl)-benzène-1 ,3-diol  12: 4- (6-Oxa-spiro [4.5] dec-9-yl) -benzene-1,3-diol
13 : 4-Chloro-6-(tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  13: 4-Chloro-6- (tetrahydro-pyran-4-yl) -benzene-1,3-diol
14 : 4-Fluoro-6-(tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  14: 4-Fluoro-6- (tetrahydro-pyran-4-yl) -benzene-1,3-diol
15 : 4-(2,2-Diethyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  15: 4- (2,2-Diethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
16 : 4-(tétrahydro-pyran-3-yl)-benzène-1 ,3-diol 16: 4- (tetrahydro-pyran-3-yl) -benzene-1,3-diol
17 : trans-4-(5-Hydroxyméthyl-tétrahydro-furan-3-yl)-benzène-1 ,3-diol  17: trans-4- (5-Hydroxymethyl-tetrahydro-furan-3-yl) -benzene-1,3-diol
18 : cis-4-(5-Hydroxyméthyl-tétrahydro-furan-3-yl)-benzène-1 ,3-diol  18: cis-4- (5-Hydroxymethyl-tetrahydro-furan-3-yl) -benzene-1,3-diol
19 : trans-4-Fluoro-6-(5-hydroxyméthyl-tétrahydro-furan-3-yl)-benzène-1 ,3-diol  19: trans-4-Fluoro-6- (5-hydroxymethyl-tetrahydro-furan-3-yl) -benzene-1,3-diol
20 : cis-4-Fluoro-6-(5-hydroxyméthyl-tétrahydro-furan-3-yl)-benzène-1 ,3-diol 21 : trans-4-Fluoro-6-(2-hydroxyméthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol 20: cis-4-Fluoro-6- (5-hydroxymethyl-tetrahydro-furan-3-yl) -benzene-1,3-diol 21: trans-4-Fluoro-6- (2-hydroxymethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
22 : cis-4-Fluoro-6-(2-hydroxyméthyl-tétrahydro-pyran-4-yl)-benzène-1 ,3-diol  22: cis-4-Fluoro-6- (2-hydroxymethyl-tetrahydro-pyran-4-yl) -benzene-1,3-diol
23 : cis-4-(8-Oxa-bicyclo[3.2.1 ]oct-3-yl)-benzène-1 ,3-diol  23: cis-4- (8-Oxa-bicyclo [3.2.1] oct-3-yl) -benzene-1,3-diol
24 : trans-4-(8-Oxa-bicyclo[3.2.1 ]oct-3-yl)-benzène-1 ,3-diol  24: trans-4- (8-Oxa-bicyclo [3.2.1] oct-3-yl) -benzene-1,3-diol
25 : 4-Fluoro-6-(tétrahydro-thiopyran-4-yl)-benzène-1 ,3-diol. 25: 4-Fluoro-6- (tetrahydro-thiopyran-4-yl) -benzene-1,3-diol.
4 - Composition selon l'une des revendications 1 à 3 caractérisé en ce que le composé de formule (I) est le 4-(tétrahydro-pyran-4-yl)-benzène-1 ,3-diol. 5. Composition selon l'une des revendications 1 à 4, caractérisée en ce que le ou les composés de formule (I) sont présents en une teneur allant de de 0,001 % à 10 % en poids, par rapport au poids total de la composition, plus particulièrement en une teneur allant de 0,05 % à 5 % en poids, et de préférence allant de 0,1 % à 3 % en poids, et préférentiellement allant de 0,25 % à 2 % en poids. 4 - Composition according to one of claims 1 to 3 characterized in that the compound of formula (I) is 4- (tetrahydro-pyran-4-yl) -benzene-1,3-diol. 5. Composition according to one of claims 1 to 4, characterized in that the compound (s) of formula (I) are present in a content ranging from 0.001% to 10% by weight, relative to the total weight of the composition more particularly in a content ranging from 0.05% to 5% by weight, and preferably ranging from 0.1% to 3% by weight, and preferably ranging from 0.25% to 2% by weight.
6. Composition selon l'une quelconque des revendications précédentes, caractérisée en ce que le(s)dit glycol a) est choisi(s) parmi le propylène glycol, le butylène glycol, le pentylène glycol, l'hexylène glycol, le dipropylène glycol, le diéthylène glycol, le 1 ,3- propanediol, le 1 ,5-pentanediol, les polyéthylènes glycol, et un de leurs mélanges. 6. Composition according to any one of the preceding claims, characterized in that (s) said glycol a) is chosen from propylene glycol, butylene glycol, pentylene glycol, hexylene glycol, dipropylene glycol diethylene glycol, 1,3-propanediol, 1,5-pentanediol, polyethylene glycol, and a mixture thereof.
7. Composition selon l'une quelconque des revendications précédentes, caractérisée en ce que le(s)dit glycol(s) est choisi(s) parmi le dipropylène glycol, le propylène glycol, le butylène glycol, et leurs mélanges. 7. Composition according to any one of the preceding claims, characterized in that said glycol (s) is chosen from dipropylene glycol, propylene glycol, butylene glycol, and mixtures thereof.
8. Composition selon l'une quelconque des revendications précédentes, caractérisée par le fait que le(s)dit glycol(s) est présent(s) en une teneur allant de 0,5 % à 60 % en poids, par rapport au poids total de la composition, de préférence allant de 5 % à 50 % en poids, et préférentiellement allant de 10 % à 40 % en poids, par rapport au poids total de la composition. 8. Composition according to any one of the preceding claims, characterized in that the said glycol (s) is present (s) in a content ranging from 0.5% to 60% by weight, relative to the weight total of the composition, preferably ranging from 5% to 50% by weight, and preferably ranging from 10% to 40% by weight, relative to the total weight of the composition.
9. Composition selon l'une quelconque des revendications précédentes, caractérisée en ce que le ou les monoalcools en C2-C4 est(sont) choisis parmi l'éthanol, le propanol, l'isopropanol, le butanol-1 , l'isobutanol et leurs mélanges et est de préférence l'éthanol. 9. Composition according to any one of the preceding claims, characterized in that the C 2 -C 4 monohydric alcohol (s) is (are) chosen from ethanol, propanol, isopropanol, butanol-1 and isobutanol. mixtures thereof and is preferably ethanol.
10. Composition selon l'une quelconque des revendications précédentes, caractérisée en ce que le ou les monoalcools en C2-C4 est(sont) présent(s) à une teneur allant de 0,1 % à 30 % en poids, de préférence de 0,5 % à 15 % en poids, par rapport au poids total de la composition. 10. Composition according to any one of the preceding claims, characterized in that the C2-C4 monohydric alcohol (s) is (are) present in a content ranging from 0.1% to 30% by weight, preferably from 0.5% to 15% by weight, relative to the total weight of the composition.
1 1 . Composition selon l'une quelconque des revendications précédentes, dans laquelle le rapport massique du(des)dit monoalcool/composé d) de formule (I) va 1 à 20, de préférence de 1 ,5 à 10. 1 1. Composition according to any one of the preceding claims, in which the weight ratio of the said monoalcohol / compound d) of formula (I) ranges from 1 to 20, preferably from 1.5 to 10.
12. Composition selon l'une quelconque des revendications précédentes, caractérisée en ce qu'elle comprend en outre de la glycérine. 12. Composition according to any one of the preceding claims, characterized in that it further comprises glycerine.
13. Composition selon la revendication précédente, caractérisée en ce la glycérine est présente dans des concentrations allant de 0,1 % à 60 % en poids, de préférence de 1 % à 50 % en poids, de préférence de 5 à 30% en poids par rapport au poids total de la composition. 13. Composition according to the preceding claim, characterized in that the glycerin is present in concentrations ranging from 0.1% to 60% by weight, preferably from 1% to 50% by weight, preferably from 5 to 30% by weight. relative to the total weight of the composition.
14. Composition selon l'une quelconque des revendications précédentes, caractérisée en ce qu'elle se présente sous la forme d'une émulsion eau-dans-huile ou huile-dans-eau, de préférence une émulsion huile-dans-eau. 14. Composition according to any one of the preceding claims, characterized in that it is in the form of a water-in-oil or oil-in-water emulsion, preferably an oil-in-water emulsion.
15. Composition selon l'une quelconque des revendications précédentes, caractérisée en ce qu'elle est une composition cosmétique. 15. Composition according to any one of the preceding claims, characterized in that it is a cosmetic composition.
16. Procédé de traitement cosmétique des matières kératiniques comprenant l'application sur les matières kératiniques, telles que la peau, d'une composition selon l'une quelconque des revendications précédentes. 16. A process for the cosmetic treatment of keratin materials comprising the application to keratin materials, such as the skin, of a composition according to any one of the preceding claims.
17 Procédé cosmétique de dépigmentation, d'éclaircissement et/ou de blanchiment des matières kératiniques, notamment la peau humaine, les poils ou les cheveux comprenant l'application sur lesdites matières kératiniques d'une composition telle que définie selon l'une quelconque des revendications 1 à 15. 17 A cosmetic process for depigmenting, lightening and / or bleaching keratinous substances, in particular human skin, hair or hair, comprising applying to said keratin materials a composition as defined according to any one of the claims 1 to 15.
PCT/EP2015/080652 2014-12-22 2015-12-18 Aqueous composition comprising a 4-(heterocycloalkyl)-benzene-1,3-diol compound, a c2-c4 monoalcohol, and a glycol WO2016102402A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1463148A FR3030252B1 (en) 2014-12-22 2014-12-22 AQUEOUS COMPOSITION COMPRISING A 4- (HETEROCYCLOALKYL) -BENZENE-1,3-DIOL COMPOUND, A C2-C4 MONOALCOOL AND A GLYCOL
FR1463148 2014-12-22

Publications (1)

Publication Number Publication Date
WO2016102402A1 true WO2016102402A1 (en) 2016-06-30

Family

ID=52692860

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2015/080652 WO2016102402A1 (en) 2014-12-22 2015-12-18 Aqueous composition comprising a 4-(heterocycloalkyl)-benzene-1,3-diol compound, a c2-c4 monoalcohol, and a glycol

Country Status (2)

Country Link
FR (1) FR3030252B1 (en)
WO (1) WO2016102402A1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220117871A1 (en) * 2018-02-12 2022-04-21 Venn Skincare, Inc. Water-solubilized mixture of ginsenoside compound k and method of watersolubilizing ginsenoside compound k

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2939136A1 (en) * 2008-12-02 2010-06-04 Galderma Res & Dev NOVEL 4- (HETEROCYCLOALKYL) -BENZENE-1,3-DIOL COMPOUNDS AS TYROSINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2939136A1 (en) * 2008-12-02 2010-06-04 Galderma Res & Dev NOVEL 4- (HETEROCYCLOALKYL) -BENZENE-1,3-DIOL COMPOUNDS AS TYROSINASE INHIBITORS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN HUMAN MEDICINE AND COSMETICS

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20220117871A1 (en) * 2018-02-12 2022-04-21 Venn Skincare, Inc. Water-solubilized mixture of ginsenoside compound k and method of watersolubilizing ginsenoside compound k

Also Published As

Publication number Publication date
FR3030252B1 (en) 2018-11-02
FR3030252A1 (en) 2016-06-24

Similar Documents

Publication Publication Date Title
RU2589827C2 (en) Cosmetic composition containing 4-(3-ethoxy-4-hydroxyphenyl)-2-butanone
KR101925161B1 (en) Cosmetic composition comprising a cucurbic acid compound and a hydrophobic inulin
FR2973228A1 (en) COSMETIC COMPOSITION COMPRISING 4- (3-ETHOXY-4-HYDROXYPHENYL) BUTAN-2-ONE
EP1269986B1 (en) Compositions comprising a compound of low solubility and a lipophilic amino acid derivative, and corresponding uses and processes
FR2950884A1 (en) USE OF VANILLIN DERIVATIVES AS A PRESERVATIVE, METHOD OF PRESERVATION, COMPOUNDS AND COMPOSITION
EP2100586B1 (en) Cosmetic composition comprising an ascorbic acid or salicylic acid compound
FR3117799A1 (en) Composition comprising aqueous gelling agents, surfactant, oils, fillers and ascorbic acid
EP2694027B1 (en) Use of (ethoxy-hydroxy phenyl)alkyl ketone or ethoxy hydroxy alkyl phenol compounds for treating oily skin
FR2928541A1 (en) Composition, useful for care/make-up of keratin materials e.g. lips, comprises: fatty acid ester and polyethylene glycol; additional surfactant; polycondensate of ethylene oxide and propylene oxide; and active ingredient e.g. ascorbic acid
FR3008611A1 (en) COSMETIC COMPOSITION COMPRISING A CUCURBIC ACID COMPOUND AND ANIONIC SURFACTANT DERIVED FROM AMINO ACID
FR2780646A1 (en) COSMETIC AND / OR DERMATOLOGICAL COMPOSITION CONTAINING SALICYLIC ACID DERIVATIVES AND METHOD FOR INTRODUCING DERIVATIVES THEREOF IN AQUEOUS COMPOSITION
WO2016102402A1 (en) Aqueous composition comprising a 4-(heterocycloalkyl)-benzene-1,3-diol compound, a c2-c4 monoalcohol, and a glycol
FR3007652A1 (en) COMPOSITION COMPRISING DOCOSAHEXAENOIC ACID AND PENTAERYTHRITYL TETRA-DI-T-BUTYL HYDROXYHYDROCINNAMATE
FR3029780A1 (en) COMPOSITION COMPRISING HESPERETIN
WO2016102399A1 (en) Aqueous composition comprising a 4-(heterocycloalkyl)-benzene-1,3-diol compound and a hydrotrope
WO2016102400A1 (en) Composition comprising a 4-(heterocycloalkyl)-benzene-1,3-diol compound and a specific solvent
WO2014170591A1 (en) Cosmetic composition comprising a cucurbic acid compound and a (poly)oxyalkylenated polar oil
FR2928540A1 (en) Composition, useful for care/make-up of keratin materials e.g. lips, comprises: fatty acid ester and polyethylene glycol; additional surfactant; polycondensate of ethylene oxide and propylene oxide; and active ingredient e.g. ascorbic acid
WO2016102398A1 (en) Aqueous composition comprising a 4-(heterocycloalkyl)-benzene-1,3-diol compound, a polymer and a glycol
FR2826273A1 (en) Compositions, useful for depigmenting or bleaching hyperpigmented skin , comprise a compound of low solubility and a lipophilic amino acid derivative give stable emulsions
FR2984119A1 (en) Composition, useful for caring and/or making up skin and treating greasy skin, comprises substituted 2,5-dioxopyrrolidin-1-yl compounds and organic solvents having a specified solubility parameter in an aqueous medium
FR3002443B1 (en) COMPOSITION CONTAINING REBAUDIOSIDE A AND OXYETHYLENE SURFACTANT
FR3029783A1 (en) AQUEOUS COMPOSITION COMPRISING HESPERETIN
FR3131841A1 (en) C omposition comprising oil, water-soluble alcohol and an ingredient derived from water lily plants
FR3132019A1 (en) MOISTURIZING EXFOLIATING CREAM FOR SKIN PERFECTION

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15816168

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 15816168

Country of ref document: EP

Kind code of ref document: A1